Interleukin-6 as a Predictive Factor of Pathological Response to FLOT Regimen Systemic Treatment in Locally Advanced Gastroesophageal Junction or Gastric Cancer Patients.
Katarzyna Marcisz-GrzankaBeata KotowiczAleksandra NowakMariola WiniarekMalgorzata FuksiewiczMaria KowalskaAndrzej TysarowskiTomasz OlesińskiJakub PaluckiUrszula SulkowskaAgnieszka Kolasinska-CwiklaLucjan Stanislaw WyrwiczPublished in: Cancers (2024)
The trial showed that an elevated level of IL-6 prior to treatment and C2 might be a predictor of pathological response to NAC.